07/24/2017

NCCN has published updates to the NCCN Guidelines and NCCN Compendium® for Uterine Neoplasms

NCCN has published updates to the NCCN Guidelines and NCCN Compendium^® for Uterine Neoplasms. These NCCN Guidelines are currently available as Version 3.2017. 

• Uterine Sarcoma
  • The combination “doxorubicin/olaratumab” was added as a systemic therapy option for the treatment of uterine sarcoma.
• The Discussion section has been updated to reflect the changes in the algorithm. (MS-1)

*For your reference, the previous update (Version 2.2017) to the NCCN Guidelines for Uterine Neoplasms, published on April 25, 2017,  is available at the following link: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#uterine